The intestine-specific homeobox gene Cdx2 decreases mobility and antagonizes dissemination of colon cancer cells
The gravity of colorectal cancer is mainly due to the capacity of tumor cells to migrate out of the tumor mass to invade the stroma and disseminate as metastases. The acquisition of a migratory phenotype also occurs during wound healing. Here, we show that several features characterizing invasive co...
Saved in:
Published in | Oncogene Vol. 27; no. 1; pp. 107 - 115 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
03.01.2008
Nature Publishing Nature Publishing Group Nature Publishing Group [1987-....] |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The gravity of colorectal cancer is mainly due to the capacity of tumor cells to migrate out of the tumor mass to invade the stroma and disseminate as metastases. The acquisition of a migratory phenotype also occurs during wound healing. Here, we show that several features characterizing invasive colon tumor cells are shared by migrating cells during wound repair
in vitro
. In particular, the expression of the intestine-specific transcription factor
Cdx2
, a key gene for intestinal identity downregulated in invasive cancer cells, is reduced during wound healing
in vitro
. Transcription factors involved in epithelial–mesenchymal transition such as Snail and Slug are upregulated during wound healing and are able to repress
Cdx2
transcription.
In vitro
, forced expression of Cdx2 in human colon cancer cell lines retarded wound repair and reduced migration, whereas inhibition of Cdx2 expression by RNA interference enhanced migration.
In vivo
, forced expression of Cdx2 opposed tumor cells spreading in nude mice xenografted at three different sites. These data provide evidence that
Cdx2
antagonizes the process of tumor cell dissemination, and they suggest that this homeobox gene might represent a new therapeutic target against metastatic spreading of colon cancer. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/sj.onc.1210601 |